Mycobacterium bovis BCG killed by extended freeze‐drying induces an immunoregulatory profile and protects against atherosclerosis
- 20 August 2013
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 275 (1), 49-58
- https://doi.org/10.1111/joim.12127
Abstract
Objectives Atherosclerosis is an inflammatory disease of the arterial wall that leads to myocardial infarction and stroke. Regulatory T cells (Tregs) and IL‐10 exert significant anti‐atherogenic effects in experimental models of atherosclerosis by modulating vascular inflammation. We have previously shown that Mycobacterium bovis BCG killed by extended freeze‐drying (EFD BCG) decreases lung and colon inflammation by recruiting IL‐10‐producing Tregs. Therefore, the aim of this study was to investigate the effect of EFD BCG on the development of atherosclerosis. Design We used two strains of atherosclerosis‐prone mice: Ldlr−/− (four or six EFD BCG injections) and Apoe−/− (six injections). Results In both models, EFD BCG significantly reduced the size of atherosclerotic lesions, increased IL‐10 production and reduced the serum levels of pro‐inflammatory cytokines (IL‐6, IL‐13, KC and tumour necrosis factor‐α). Shortly after treatment with EFD BCG, the number of plasmacytoid dendritic cells (pDCs) and Foxp3+ Tregs in the draining lymph nodes increased. EFD BCG also led to accumulation of Tregs, but not of pDCs in the spleen, and reduced activity of NF‐κB and increased activity of PPAR‐γ in both the spleen and vascular tissue of treated mice. Conclusion EFD BCG has atheroprotective effects through IL‐10 production and Treg expansion. These findings support a novel approach to the prevention and treatment of atherosclerosis.Keywords
Funding Information
- Immunotherapix
- Karolinska University Hospital
- Leducq Foundation
- European Union
- Institut Pasteur
- INRA
- OSEO
- la Mairie de Paris
- Swedish Research Council
- Swedish Heart-Lung Foundation
- Stockholm County Council/ALF
- Foundation for Strategic Research
This publication has 34 references indexed in Scilit:
- IL-27 induces the differentiation of Tr1-like cells from human naive CD4+ T cells via the phosphorylation of STAT1 and STAT3Immunology Letters, 2011
- Immunotherapy With Tolerogenic Apolipoprotein B-100–Loaded Dendritic Cells Attenuates Atherosclerosis in Hypercholesterolemic MiceCirculation, 2011
- Signal transducer and activator of transcription 4 limits the development of adaptive regulatory T cellsImmunology, 2009
- Identification and characterization of IL-10/IFN-γ–producing effector-like T cells with regulatory function in human bloodThe Journal of Experimental Medicine, 2009
- Signal Transducer and Activator of Transcription 4 Is Required for the Transcription Factor T-bet to Promote T Helper 1 Cell-Fate DeterminationImmunity, 2008
- LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanismsRespiratory Research, 2007
- Synergistic effects of RXR and PPAR ligands to inhibit growth in human colon cancer cells phosphorylated RXR is a critical target for colon cancer managementGut, 2007
- Plasmacytoid dendritic cells prime IL-10–producing T regulatory cells by inducible costimulator ligandThe Journal of Experimental Medicine, 2007
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseThe New England Journal of Medicine, 2005
- Interferon-γ Produced by Bone Marrow-derived Cells Attenuates Atherosclerotic Lesion Formation in LDLR-deficient MiceJournal of Atherosclerosis and Thrombosis, 2004